Asset Intelligence / Hyperliquid Context
SPDR S&P Biotech ETF / BIOTECH
Market guides and dated reports for BIOTECH. Browse recent coverage below or use the archive pages to find older articles.
BIOTECH tracks the XBI ETF, which represents the engine of medical innovation. It uses an equal-weighted approach to capture the biotechnology sector, providing high-growth exposure to smaller firms developing next-gen drugs and life-saving therapies.
Archive Summary
Latest Archived Thesis
How to Trade SPDR S&P Biotech ETF (BIOTECH) on Hyperliquid
BIOTECH is a HIP-3 perpetual futures contract tracking the SPDR S&P Biotech ETF (XBI), an equal-weighted fund holding 151 biotechnology companies. It gives traders 24/7 leveraged exposure to the full spectrum of U.S. biotech, from clinical-stage startups to large-cap names like Moderna and Gilead. The perp is available on Hyperliquid with up to 20x leverage.
Archive
BIOTECH Article Archive
Background reading selected from this asset's symbol, builder context, and archived catalyst coverage.
HIP-3 Explained: Builder-Deployed Perps on Hyperliquid
HIP-3 lets anyone deploy a perpetual futures market on Hyperliquid — no approval, no gatekeepers. Builder mechanics, fees, and live markets.
Funding Rates Explained: A Trader's Guide (2026)
Funding rates decide if you pay or earn holding a perp position. How Hyperliquid's hourly funding works, reading rate signals, and cash-and-carry arbitrage.